Skip to main content
Log in

Analysis of Anti-Glycan IgG and IgM Antibodies in Colorectal Cancer

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We propose an approach that allows simultaneous determination of the levels of M and G isotypes of antibodies to the panel of glycans using microarrays. The level of IgG antibodies to 3’-O-su-Lea glycan detects patients with colorectal cancer with a sensitivity of 69.77% and specificity of 62.75%. The percentage of correctly classified colorectal cancer patients with the use of a combination of two markers IgM antibodies to glycans 3’-sialyl-TF and 3’-O-su-Lea is as high as 74.23%. The levels of IgM antibodies to 3’-O-su-Lea glycan differ significantly in patients with and without regional metastases. The levels of some of antiglycan IgM or IgG antibodies differed significantly in patients with tumors of different location and differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Borrebaeck CA. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat. Rev. Cancer. 2017;17(3):199-204.

    Article  CAS  PubMed  Google Scholar 

  2. Butvilovskaya VI, Popletaeva SB, Chechetkin VR, Zubtsova ZI, Tsybulskaya MV, Samokhina LO, Vinnitskii LI, Ragimov AA, Pozharitskaya EI, Grigor Eva GA, Meshalkina NY, Golysheva SV, Shilova NV, Bovin NV, Zasedatelev AS, Rubina AY. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Med. 2016;5(7):1361-1372.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cao X, Wen ZS, Sun YJ, Li Y, Zhang L, Han YJ. Prognostic value of ABO blood group in patients with surgically resected colon cancer. Br. J. Cancer. 2014;111(1):174-180.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L, Sturgeon C. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int. J. Cancer. 2014;134(11):2513-2522.

    Article  CAS  PubMed  Google Scholar 

  5. Geissner A, Seeberger PH. Glycan arrays: from basic biochemical research to bioanalytical and biomedical applications. Annu. Rev. Anal. Chem. (Palo Alto Calif). 2016;9(1):223-247.

    Article  CAS  Google Scholar 

  6. Jacob F, Anugraham M, Pochechueva T, Tse BW, Alam S, Guertler R, Bovin NV, Fedier A, Hacker NF, Huflejt ME, Packer N, Heinzelmann-Schwarz VA. The glycosphingolipid P 1 is an ovarian cancer-associated carbohydrate antigen involved in migration. Br. J. Cancer. 2014;111(8):1634-1645.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Meany DL, Chan DW. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin. Proteomics. 2011;8(1):7. doi: https://doi.org/10.1186/1559-0275-8-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Muthana SM, Gildersleeve JC. Glycan microarrays: powerful tools for biomarker discovery. Cancer Biomark. 2014;14(1):29-41.

    Article  CAS  PubMed  Google Scholar 

  9. Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer. 2015;15(9):540-555.

    Article  CAS  PubMed  Google Scholar 

  10. Pochechueva T, Chinarev A, Schoetzau A, Fedier A, Bovin NV, Hacker NF, Jacob F, Heinzelmann-Schwarz V. Blood plasma-derived anti-glycan antibodies to sialylated and sulfated glycans identify ovarian cancer patients. PLoS One. 2016;11(10):e0164230. doi: https://doi.org/10.1371/journal.pone.0164230.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Rubina AY, Dementieva EI, Stomakhin AA, Darii EL, Pan’kov SV, Barsky VE, Ivanov SM, Konovalova EV, Mirzabekov AD. Hydrogel-based protein microchips: manufacturing, properties, and applications. Biotechniques. 2003;34(5):1008-1022.

    Article  CAS  PubMed  Google Scholar 

  12. Tikhonov AA, Tsybulskaya MV, Butvilovskaya VI, Savvateeva EN, Belousov PV, Kuprash DV, Solopova ON, Chernichenko MA, Filushin MM, Rubina AY. Differential quantification of SCCA1 and SCCA2 cancer antigens using a hydrogel biochip. Anal. Methods. 2016;8(44):7920-7928.

    Article  CAS  Google Scholar 

  13. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015;65(2):87-108.

    Article  PubMed  Google Scholar 

  14. Vollmers HP, Brändlein S. Natural antibodies and cancer. N. Biotechnol. 2009;25(5):294-298.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. A. Tikhonov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 10, pp. 485-490, October, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tikhonov, A.A., Savvateeva, E.N., Chernichenko, M.A. et al. Analysis of Anti-Glycan IgG and IgM Antibodies in Colorectal Cancer. Bull Exp Biol Med 166, 489–493 (2019). https://doi.org/10.1007/s10517-019-04379-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04379-2

Key Words

Navigation